Board of Bliss GVS Pharma recommends final dividend
Of Re 0.50 per share
Bliss GVS Pharma announced that the Board of Directors of the Company at
its meeting held on 26 May 2014, inter alia, has recommended a final
dividend of 50% i.e. Re 0.50 per equity share for the year ended 31 March
2014.